BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Pharnext: Successful Intermediate Analyses for PLEO-CMT Phase III Clinical Trial in Charcot-Marie-Tooth Disease Type 1A

  PLEO-CMT study to continue as planned without increasing the number of patients.

  November 29, 2017

   · 

  3 min read
• Biotech Bay

  Cesca Therapeutics Announces Pricing of Public Offering of Up to 900,000 Shares of Common Stock

  The offering is expected to close on or about December 1, 2017, subject to the satisfaction of customary closing conditions.

  November 29, 2017

   · 

  3 min read
• Biotech Beach

  Scientists at TSRI and Synthorx Create the First Semi-Synthetic Organism to Encode and Translate Expanded Genetic Information Into a Novel Protein With Different Non-Natural Amino Acids

  Synthorx announced today that scientists at TSRI and the company, guided by Floyd Romesberg, Ph.D., have developed the first semi-synthetic organism that can store and retrieve increased genetic information.

  November 29, 2017

   · 

  4 min read
• Policy

  Pillar Biosciences Announces ISO 13485: 2016 Certification

  The first Pillar Biosciences assay produced under this QMS is the recently-launched ONCO/REVEAL BRCA 1/2 panel targeting the entire coding region of the BRCA genes.

  November 29, 2017

   · 

  1 min read
• FDA

  Innovus Pharma’s Partner Bio Task Receives Approval for Zestra as a Cosmetic from the National Pharmaceutical Regulatory Agency, Ministry of Health, Malaysia for Arousal and Desire

  Innovus Pharma signed in November 2015 an exclusive license and distribution agreement with Bio Task.

  November 29, 2017

   · 

  5 min read
• Business

  Pediapharm Announces Death of Director

  Pediapharm announces with great sadness that Mr. Douglas M. Stuve, an independent member of the Company’s Board of Directors, passed away on November 23, 2017.

  November 29, 2017

   · 

  1 min read
• Pharm Country

  AmerisourceBergen Prices $750M 3.45% Senior Notes Due 2027 and $500M 4.30% Senior Notes Due 2047

  The offering is expected to close on December 4, 2017, subject to customary closing conditions.

  November 29, 2017

   · 

  8 min read
• Business

  Revive Therapeutics Announces Results for the Three Months Ended September 30, 2017

  The unaudited condensed interim consolidated financial statements and related interim management’s discussion and analysis for the three months ended September 30, 2017 may be viewed on SEDAR at www.sedar.com.

  November 29, 2017

   · 

  6 min read
• Business

  RightEye Partners With Tobii on New Eye-Tracking System for Vision Tests

  Through the deal, the companies will co-develop new hardware solutions to complement RightEye vision tests and training games for customers in vision, health care and sports markets.

  November 29, 2017

   · 

  3 min read
• Drug Development

  Amphivena Receives Orphan Drug Designation for AMV564, a Novel CD33/CD3 T-Cell Engagement Therapy for the Treatment of Acute Myeloid Leukemia

  Amphivena is conducting a Phase 1 clinical study of AMV564 in relapsed or refractory AML.

  November 29, 2017

   · 

  2 min read